About 1,805 results

ALLMedicine™ Insulinoma Center

Research & Reviews  689 results

Is the size of insulinoma predictive for its endocrine behavior? An endoscopic ultrasou...
Experimental and Clinical Endocrinology & Diabetes : Offi... Adelmeyer J, Göbel F et. al.

May 3rd, 2022 - The insulinoma is a rare tumor of the pancreas, that can lead to spontaneous hypoglycemia due to an excessive insulin secretion. The 72-hour fast is the gold standard for finding the correct diagnosis. Endoscopic ultrasound (EUS) is an established...

Long delay in diagnosis of a case with MEN1 due to concomitant presence of AIMAH with i...
BMC Endocrine Disorders; Chavoshi V, Tamehri Zadeh SS et. al.

Apr 23rd, 2022 - ACTH-independent macronodular hyperplasia (AIMAH) is an uncommon disorder characterized by massive enlargement of both adrenal glands and hypersecretion of cortisol. Concomitant AIMAH and multiple endocrine neoplasia type1 (MEN1) is rare to our kn...

Latent autoimmune diabetes in youth shows greater autoimmunity than latent autoimmune d...
Pediatric Diabetes; Cheng J, Tang X et. al.

Apr 23rd, 2022 - To investigate the prevalence and clinical features of latent autoimmune diabetes in youth (LADY) diagnosed between 15 and 29 years old as a component of an age-related autoimmune diabetes spectrum. This nationwide, multicenter, cross-sectional st...

Laparoscopic Enucleation of Pancreatic Neoplasms: A Single-Center Experience and Outcomes.
Journal of Laparoendoscopic & Advanced Surgical Technique... Bruballa R, Fratantoni ME et. al.

Apr 22nd, 2022 - Background: Laparoscopic technique has been increasingly applied in the treatment of selected pancreatic tumors. The aim of this study is to evaluate the experience with laparoscopic enucleation of pancreatic neoplasms (LEPNs), for selected pancre...

Pancreatic Carcinoid Tumor in a Pediatric Patient.
The American Journal of Case Reports; Musalli DI, Binafif YA et. al.

Apr 9th, 2022 - BACKGROUND Carcinoid tumors are well-differentiated tumors that develop from neuroendocrine cells. They are rare tumors and occur most commonly in the gastrointestinal tract, followed by the pulmonary system. They usually present with abdominal pa...

see more →

Clinicaltrials.gov  5 results

Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes

Oct 8th, 2020 - Autoimmune diseases are the outcome of dysregulated immune responses to self-antigens. Type 1 diabetes (T1D), previously known as insulin-dependent or juvenile diabetes, is an autoimmune disease in which the body's immune system reacts against and...

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Jan 30th, 2020 - Congenital Hyperinsulinism (HI) is a disorder of insulin secretion that causes profound hypoglycemia leading to significant morbidity. It is the most common form of persistent neonatal hypoglycemia, and the most dangerous. Inappropriate insulin se...

Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma

Dec 4th, 2019 - Since GLP-1R is expressed in human β-cells and highly overexpressed in insulinomas,multiple GLP-1R-targeted radiopharmaceuticals were devoted to insulinoma localization imaging.68Ga-NOTA-MAL-Cys39-exendin-4 is an optimal probe targeting GLP-1R. A...

New Imaging Procedure for the Localisation of Insulinoma

Apr 18th, 2018 - Insulinoma: Insulinoma are rare, small insulin secreting neuroendocrine tumors. The only curative approach is the surgical excision. The preoperative detection remains a challenge. A non-invasive, highly sensitive tool in localizing the insulinoma...

Laparoscopy to Remove Pancreatic Tumors (Insulinomas)

Mar 4th, 2008 - Patients with the clinical diagnosis of hypoglycemia secondary to a putative insulin secreting pancreatic neuroendocrine tumor require accurate localization of the tumor and definitive surgical resection. Non-invasive pre-operative imaging studies...

see more →

News  27 results

Genomic Diversity Clouds Outlook for Neuroendocrine Tumors

Dec 5th, 2020 - Despite a spate of therapeutic advances in recent years, neuroendocrine (NET) tumors remain a poorly investigated collection of cancers whose rarity has limited clinical trial enrollment. Now, genome sequencing studies are providing clues for ther...

Mystery hypoglycemia case highlights troublesome diagnosis
MDedge Endocrinology; Randy Dotinga

May 11th, 2019 - LOS ANGELES – The 69-year-old woman with a history of type 2 diabetes had persistent hypoglycemia despite treatment with hydrocortisone, dextrose, and glucagon. Doctors in South Carolina worried about insulinoma and planned to launch an intra-arte.

Beta Cell Regeneration; Essure's Afterlife; T2D and Erectile Dysfunction

Dec 21st, 2018 - Researchers at Mount Sinai discovered a combination of two drug classes that yielded the highest proliferation rate of human beta cells. This "makes beta cells regenerate at rates that are suitable for treatment. The next big hurdle is figuring ou...

Genomic Diversity Clouds Outlook for Neuroendocrine Tumors

Sep 8th, 2016 - Despite a spate of therapeutic advances in recent years, neuroendocrine (NET) tumors remain a poorly investigated collection of cancers whose rarity has limited clinical trial enrollment. Now, genome sequencing studies are providing clues for ther...

High-dose oral insulin offers immunotherapy hope against type 1 diabetes
Clinical Endocrinology News; Bianca Nogrady

Apr 21st, 2015 - High-dose oral insulin induces an immune response in children at high risk of developing type 1 diabetes but without causing hypoglycemia or triggering immune responses typical of type 1 diabetes, a pilot study showed. Children aged 2-7 with a fam.

see more →

Patient Education  1 results see all →